Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001689548-25-000058
Filing Date
2025-05-02
Accepted
2025-05-02 08:38:06
Documents
66
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q prax-20250331.htm   iXBRL 10-Q 776927
2 EX-31.1 exhibit31120250331.htm EX-31.1 13041
3 EX-31.2 exhibit31220250331.htm EX-31.2 14360
4 EX-32.1 exhibit32120250331.htm EX-32.1 13356
  Complete submission text file 0001689548-25-000058.txt   5140403

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT prax-20250331.xsd EX-101.SCH 41863
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT prax-20250331_cal.xml EX-101.CAL 55243
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT prax-20250331_def.xml EX-101.DEF 179815
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT prax-20250331_lab.xml EX-101.LAB 544537
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT prax-20250331_pre.xml EX-101.PRE 360570
68 EXTRACTED XBRL INSTANCE DOCUMENT prax-20250331_htm.xml XML 602759
Mailing Address 99 HIGH STREET, 30TH FLOOR BOSTON MA 02110
Business Address 99 HIGH STREET, 30TH FLOOR BOSTON MA 02110 617-300-8460
Praxis Precision Medicines, Inc. (Filer) CIK: 0001689548 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39620 | Film No.: 25905612
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)